Chief Strategy Officer (CSO) @ (January 2024 - November 2025)
Senior Vice President of Strategy and Development @ (September 2022 - January 2024)
Vice President of Market Development @ (July 2017 - August 2022)
Regional Director of Sales and Marketing @ (May 2013 - July 2017)
Neuroscience Senior Sales Representative @ Eli Lilly and Company (January 2008 - May 2013)
Account Executive @ Yellowbook (December 2003 - December 2007)
Sales Representative @ Emprise Marketing (July 2003 - November 2003)
Luis Cunha Education
University of Massachusetts Amherst
Bachelors of Science (Exercise Science & Physiology)
1999-2003
Luis Cunha Skills
Pharmaceutical Sales
Pharmaceutical Industry
Selling Skills
Sales Effectiveness
Diabetes
Oncology
Business Development
Urology
Medical Devices
Osteoporosis
Leadership
Account Management
Sales Operations
Selling
Neurology
Strategic Planning
Cold Calling
Market Research
Endocrinology
Rheumatology
Sales
Training
OB/GYN
Neuroscience
Cardiology
Managed Care
Gastroenterology
New Business Development
Hospital Sales
Market Access
Pulmonology
Competitive Analysis
Biotechnology
Negotiation
Salesforce.com
Sales Force Development
Cross-functional Team Leadership
Direct Sales
Dermatology
Healthcare
Infectious Diseases
Sales Process
Marketing
Psychiatry
Contract Negotiation
Marketing Strategy
Clinical Trials
Sales Management
Product Launch
Product Marketing
Public Speaking
Microsoft Excel
Cross Functional Team Leadership
Management
Luis Cunha Summary
Luis Cunha, based in Pelham, NH, US, is currently a Chief Strategy Officer (CSO) at Genesis. Luis Cunha brings experience from previous roles at Vis-À-Vis Health, CareOne and Genesis. Luis Cunha holds a 1999 - 2003 Bachelors of Science in Exercise Science & Physiology @ University of Massachusetts Amherst. With a robust skill set that includes Pharmaceutical Sales, Pharmaceutical Industry, Selling Skills, Sales Effectiveness, Diabetes and more. Luis Cunha has 2 emails and 4 mobile phone numbers on RocketReach.
Looking for a different Luis Cunha?
Find contact details for 700 million professionals.